OR WAIT null SECS
June 03, 2021
CDMO’s North Carolina production site will be engineering Covid-19 vaccine doses
May 24, 2021
Production of the key component of gene therapies and certain vaccines for Covid-19 hampered by insufficient manufacturing capacity, according to GlobalData
Vaccine maker will use CDMO’s South Korean facilities to support additional Covid doses
May 21, 2021
Expansion features a new lyophilization center to meet point-of-care demand
May 20, 2021
Facility will house 44,000 square feet of clinical and commercial cGMP, and other tech services
May 14, 2021
Expansion establishes role it plays in the oncology sector, company suggests
May 12, 2021
Pauses per manufacturer due to label-printing problems occur just under six times a year, on average, report finds
May 10, 2021
New sterile production area at Italy facility aims to benefit biologics manufacturing, such as BSL vaccines
Company also plans to design a manufacturing site for future mRNA vaccines and therapeutics
May 07, 2021
Will use new facility in Belgium for commercial production of plasmid DNA